Myeloproliferative neoplasms – a global view-Reference-Cited by-同舟云学术

Myeloproliferative neoplasms – a global view

Published:2022-04-28 Issue:6 Volume:198 Page:953-964
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tefferi Ayalew¹^ORCID,Ianotto Jean‐Christophe²^ORCID,Mathews Vikram³^ORCID,Samuelsson Jan⁴^ORCID,Szuber Natasha⁵^ORCID,Xiao Zhijian⁶,Hokland Peter⁷^ORCID

Affiliation:

1. Division of Hematology Department of Medicine Mayo Clinic Rochester Minnesota USA

2. Department of Clinical Hematology University Hospital of Brest Brest France

3. Department of Haematology Christian Medical College Vellore Tamil Nadu India

4. Department of Hematology Linköping University Hospital Linköping Sweden

5. Department of Hematology Maisonneuve‐Rosemont Hospital Montreal Canada

6. MDS and MPN Centre Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China

7. Department of Clinical Medicine Faculty of Health, Aarhus University Aarhus Denmark

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18213

Reference54 articles.

1. Editorial: Some Speculations on the Myeloproliferative Syndromes

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

3. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

4. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

5. Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rounding off our Global View series;British Journal of Haematology;2023-11

2. Distinctive Attributes of Indian Patients With Classical BCR::ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory Data;Clinical Lymphoma Myeloma and Leukemia;2023-05

3. Polycythemia vera: aspects of its current diagnosis and initial treatment;Expert Review of Hematology;2023-04-03